Investigators flouting device trials rules subject to greater FDA scrutiny
This article was originally published in Clinica
Executive Summary
The US FDA has stepped up its efforts to prevent trial investigators who have already been debarred or disqualified by the agency from taking part in further clinical studies during their disqualification period.